BioSpace News Archive

Business

OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S. financial markets on Thursday, February 24, 2022.

February 17, 2022

·

1 min read

Business

Piezo Motion Announces Expansion of Its Precision Motion Motors with New Partnership

Piezo Motion, a Brain Scientific company, and Electroline Sales, Inc. announce a partnership.

February 17, 2022

·

5 min read

Business

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2021

Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three and twelve months ended December 31, 2021.

February 17, 2022

·

28 min read

PolarityTE Announces Allowance of Fourth U.S. Patent

PolarityTE, Inc. today announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application No. 17/326,734 filed on May 21, 2021 .

February 17, 2022

·

3 min read

Neo Medical closes Swisscom Ventures-lead USD $20.6M financing round

Proceeds to accelerate the commercial deployment of Neo Medical AI-driven ADVISE™ augmented reality platform for spinal surgery.

February 17, 2022

·

3 min read

Biotech Bay

Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic

Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors.

February 17, 2022

·

5 min read

Business

LEO Pharma A/S Appoints Brian Hilberdink New President of LEO Pharma Inc. United States

LEO Pharma A/S today announced it has appointed Brian Hilberdink new Executive Vice President and President of LEO Pharma Inc. in the United States, effective March 14, 2022.

February 17, 2022

·

2 min read

BioCapital

MindMaze Secures $105 Million Financing, Led by Concord Health Partners, to Fund Growth on Heels of Banner Year and Initiates American Hospital Association Partnership

MindMaze announced it has secured a $105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate the clinical development pipeline of its industry-defining digital therapeutic solutions for a wide spectrum of neurological diseases.

February 17, 2022

·

6 min read

FDA

EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo®, Inc. has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to begin marketing and sale of the EvoEndo® Single-Use Endoscopy System.

February 17, 2022

·

4 min read

Pharm Country

Amneal Expands Injectables Portfolio with 4 New Products

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the approval of four generic injectables products.

February 17, 2022

·

7 min read